• Return to Headlines

Newlink Genetics Looks to Continue to Trade Below its Annual-Low Share Price Today

By Nick Russo

Newlink Genetics (NASDAQ:NLNK) traded today at a new 52-week low of $2.60. So far today approximately 51,000 shares have been exchanged, as compared to an average 30-day volume of 570,000 shares.

There is potential upside of 121.8% for shares of Newlink Genetics based on a current price of $2.63 and an average consensus analyst price target of $5.83. The stock should find initial resistance at its 50-day moving average (MA) of $3.58 and further resistance at its 200-day MA of $5.95.

NewLink Genetics Corporation as a biopharmaceutical company. The Company discovers, develops, and commercializes novel immuno-oncology products to helps cancer patients. NewLink Genetics operates in the United States.

Newlink Genetics share prices have moved between a 52-week high of $18.59 and the current low of $2.60 and are currently at $2.63 per share. The 200-day and 50-day moving averages have moved 1.48% lower and 3.35% lower over the past week, respectively.

SmarTrend recommended that its subscribers protect gains by selling shares of Newlink Genetics on July 30th, 2018 by issuing a Downtrend alert when the shares were trading at $3.80. Since that call, shares of Newlink Genetics have fallen 28.9%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows newlink genetics

Ticker(s): NLNK